Health and Healthcare

Abbott Laboratories : ABT

All Abbott Laboratories Articles

321 Articles

Douglas A. McIntyre | Jul 4, 2008 at 7:31 AM EDT

This Week’s BioHealth & Biotech Top Stories

We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and…

Douglas A. McIntyre | Jul 3, 2008 at 2:50 AM EDT

Media Digest 7/3/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, US stock indices entered a bear market phase. Reuters writes that Yahoo! (YHOO) and Microsoft (MSFT) are…

Douglas A. McIntyre | Jun 18, 2008 at 5:51 AM EDT

The 24/7 Wall St. Ten Worst Managed Companies In America (JAVA)(SHLD)(BSX)(SBUX)(S)(CC)(MOT)(AMD)(AIG)(PFE)

With the trading year almost half over and results from the first quarter out, 24/7 Wall St. has created the…

Douglas A. McIntyre | May 13, 2008 at 12:47 PM EDT

Setbacks Back At Boston Scientific (BSX)

Boston Scientific (BSX) has been the "gang who couldn’t shot straight" of the medical device business for some time. It…

Douglas A. McIntyre | May 9, 2008 at 6:37 AM EDT

Top 10 Pre-Market Analyst Calls (ABT, AEIS, AMSC, CREE, DRS, FORM, RAIL, NVS, PNSN, SOV)

These are ten of the impact analyst calls we are seeing this Friday morning: Abbott Labs (NYSE: ABT) started as…

Douglas A. McIntyre | Apr 7, 2008 at 3:45 PM EDT

Genentech to Set Biotech Tone For Earnings Season (DNA, OSIP, SGEN, ABT, BIIB)

Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are…

Douglas A. McIntyre | Mar 20, 2008 at 6:28 AM EDT

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading: Abbott Laboratories (NYSE:…

Douglas A. McIntyre | Feb 1, 2008 at 12:35 PM EST

FDA’s First Stent Approval Since 2004 (MDT, JNJ, BSX, ABT)

Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor…

Douglas A. McIntyre | Jan 23, 2008 at 7:58 AM EST

Pre-Market Stock News (January 23, 2008)

We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and…

Douglas A. McIntyre | Dec 7, 2007 at 12:12 PM EST

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…

Douglas A. McIntyre | Dec 4, 2007 at 6:28 PM EST

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…

Douglas A. McIntyre | Nov 30, 2007 at 4:21 AM EST

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Fed chief Bernanke said the resurgence in financial strains in recent weeks had dimmed the outlook for…

Douglas A. McIntyre | Nov 29, 2007 at 6:47 PM EST

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…

Douglas A. McIntyre | Nov 28, 2007 at 10:18 AM EST

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…

Douglas A. McIntyre | Jul 18, 2007 at 7:15 AM EDT

Pre-Market Stock News (July 18, 2007)

(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items;…

1 … 19 20 21 22

Abbott Laboratories : ABT

All Abbott Laboratories Articles

This Week’s BioHealth & Biotech Top Stories

Media Digest 7/3/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

The 24/7 Wall St. Ten Worst Managed Companies In America (JAVA)(SHLD)(BSX)(SBUX)(S)(CC)(MOT)(AMD)(AIG)(PFE)

Setbacks Back At Boston Scientific (BSX)

Top 10 Pre-Market Analyst Calls (ABT, AEIS, AMSC, CREE, DRS, FORM, RAIL, NVS, PNSN, SOV)

Genentech to Set Biotech Tone For Earnings Season (DNA, OSIP, SGEN, ABT, BIIB)

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

FDA’s First Stent Approval Since 2004 (MDT, JNJ, BSX, ABT)

Pre-Market Stock News (January 23, 2008)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Pre-Market Stock News (July 18, 2007)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Abbott Laboratories : ABT

All Abbott Laboratories Articles

This Week’s BioHealth & Biotech Top Stories

Media Digest 7/3/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

The 24/7 Wall St. Ten Worst Managed Companies In America (JAVA)(SHLD)(BSX)(SBUX)(S)(CC)(MOT)(AMD)(AIG)(PFE)

Setbacks Back At Boston Scientific (BSX)

Top 10 Pre-Market Analyst Calls (ABT, AEIS, AMSC, CREE, DRS, FORM, RAIL, NVS, PNSN, SOV)

Genentech to Set Biotech Tone For Earnings Season (DNA, OSIP, SGEN, ABT, BIIB)

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

FDA’s First Stent Approval Since 2004 (MDT, JNJ, BSX, ABT)

Pre-Market Stock News (January 23, 2008)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Pre-Market Stock News (July 18, 2007)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income